Related references
Note: Only part of the references are listed.Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study
Michael Boehm et al.
CLINICAL RESEARCH IN CARDIOLOGY (2013)
Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials
Kim Fox et al.
EUROPEAN HEART JOURNAL (2013)
Influence of background treatment with mineralocorticoid receptor antagonists on ivabradines effects in patients with chronic heart failure
Michel Komajda et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia-reperfusion injury
Kroekkiat Chinda et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression
S. Suffredini et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study
Karl Werdan et al.
CLINICAL RESEARCH IN CARDIOLOGY (2012)
Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study
Jeffrey S. Borer et al.
EUROPEAN HEART JOURNAL (2012)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
John J. V. McMurray et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)
Role of Heart Rate Reduction in the Prevention of Experimental Heart Failure Comparison Between If-Channel Blockade and β-Receptor Blockade
Peter Moritz Becher et al.
HYPERTENSION (2012)
An updated computational model of rabbit sinoatrial action potential to investigate the mechanisms of heart rate modulation
Stefano Severi et al.
JOURNAL OF PHYSIOLOGY-LONDON (2012)
Effects on Outcomes of Heart Rate Reduction by Ivabradine in Patients With Congestive Heart Failure: Is There an Influence of Beta-Blocker Dose? Findings From the SHIFT (Systolic Heart failure treatment with the If inhibitor ivabradine Trial) Study
Karl Swedberg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Heart Rate Reduction by Ivabradine Improves Aortic Compliance in Apolipoprotein E-Deficient Mice
Florian Custodis et al.
JOURNAL OF VASCULAR RESEARCH (2012)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
John J. V. McMurray et al.
EUROPEAN HEART JOURNAL (2012)
Safety of Ivabradine in Patients With Coronary Artery Disease and Left Ventricular Systolic Dysfunction (from the BEAUTIFUL Hotter Substudy)
Michal Tendera et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling
Claudio Ceconi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine
Emmanuel Canet et al.
PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: WINNERS AND FINALIST CANDIDATES OF THE PRIX GALIEN USA, INTERNATIONAL, AND PRO BONO HUMANITARIAN AWARDS 2010 (2011)
Ivabradine improves coronary flow reserve in patients with stable coronary artery disease
Emmanouil I. Skalidis et al.
ATHEROSCLEROSIS (2011)
Efficacy of Ivabradine in Combination with Beta-Blocker Versus Uptitration of Beta-Blocker in Patients with Stable Angina
E. Amosova et al.
CARDIOVASCULAR DRUGS AND THERAPY (2011)
Forecasting the Future of Cardiovascular Disease in the United States A Policy Statement From the American Heart Association
Paul A. Heidenreich et al.
CIRCULATION (2011)
Ivabradine for the treatment of stable angina pectoris in octogenarians
Ralf Koester et al.
CLINICAL RESEARCH IN CARDIOLOGY (2011)
Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study
Inger Ekman et al.
EUROPEAN HEART JOURNAL (2011)
Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy
Jean-Claude Tardif et al.
EUROPEAN HEART JOURNAL (2011)
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL
C. Ceconi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial)
Maurizio Volterrani et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Heart rate: a forgotten link in coronary artery disease?
Kim M. Fox et al.
NATURE REVIEWS CARDIOLOGY (2011)
Efficacy of Ivabradine, a Selective I-f Inhibitor, in Patients With Chronic Stable Angina Pectoris and Diabetes Mellitus
Jeffrey S. Borer et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the I-f Inhibitor Ivabradine Trial (SHIFT)
Karl Swedberg et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Impact of Off-Label Use of Ivabradine on Exercise Capacity, Gas Exchange, Functional Class, Quality of Life, and Neurohormonal Modulation in Patients With Ischemic Chronic Heart Failure
Filippo M. Sarullo et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2010)
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Karl Swedberg et al.
LANCET (2010)
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
Michael Boehm et al.
LANCET (2010)
Treatment of stable angina pectoris by ivabradine in every day practice: The REDUCTION Study
Ralf Koester et al.
AMERICAN HEART JOURNAL (2009)
Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure
Paul Milliez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Efficacy of I-f Inhibition with Ivabradine in Different Subpopulations with Stable Angina Pectoris
Michal Tendera et al.
CARDIOLOGY (2009)
Heart rate reduction with ivabradine improves energy metabolism and mechanical function of isolated ischaemic rabbit heart
Claudio Ceconi et al.
CARDIOVASCULAR RESEARCH (2009)
Vascular endothelial ageing, heartbeat after heartbeat
Eric Thorin et al.
CARDIOVASCULAR RESEARCH (2009)
Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial
Kim Fox et al.
EUROPEAN HEART JOURNAL (2009)
Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial
Jean-Claude Tardif et al.
EUROPEAN HEART JOURNAL (2009)
Characterization of the heart rate-lowering action of ivabradine, a selective If current inhibitor
Jeffrey S. Borer et al.
AMERICAN JOURNAL OF THERAPEUTICS (2008)
Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice
A. Drouin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice
Florian Custodis et al.
CIRCULATION (2008)
I-f inhibition with ivabradine - Electrophysiological effects and safety
Irina Savelieva et al.
DRUG SAFETY (2008)
Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction
Gerd Heusch et al.
EUROPEAN HEART JOURNAL (2008)
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
Kim Fox et al.
LANCET (2008)
Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial
Kim Fox et al.
LANCET (2008)
Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST)
Rainer Kolloch et al.
EUROPEAN HEART JOURNAL (2008)
The BEAUTIFUL study: Randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction baseline characteristics of the study population
Kim Fox et al.
CARDIOLOGY (2008)
Use-dependent inhibition of hHCN4 by ivabradine and relationship with reduction in pacemaker activity
C. Thollon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Preservation of coronary reserve by ivabradine-induced reduction in heart rate in infarcted rats is associated with decrease in perivascular collagen
Eduard I. Dedkov et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Long-term safety and efficacy of ivabradine in patients with chronic stable angina
Lorenzo Lopez-Bescos et al.
CARDIOLOGY (2007)
Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris - A 3-month randomised, double-blind, multicentre, noninferiority trial
Witold Ruzyllo et al.
DRUGS (2007)
Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels
A Bucchi et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina
JC Tardif et al.
EUROPEAN HEART JOURNAL (2005)
Long-term heart rate reduction induced by the selective If current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure
P Mulder et al.
CIRCULATION (2004)
Heart rate reduction during exercise-induced myocardial ischaemia and stunning
X Monnet et al.
EUROPEAN HEART JOURNAL (2004)
Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome
MB Britten et al.
CORONARY ARTERY DISEASE (2004)
Heart rate lowering by specific and selective I-f current inhibition with ivabradine - A new therapeutic perspective in cardiovascular disease
D DiFrancesco et al.
DRUGS (2004)
Effect of graded heart rate reduction with ivabradine on myocardial oxygen consumption and diastolic time in exercising dogs
P Colin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Antianginal and antiischemic effects of ivabradine, an If inhibitor, in stable angina -: A randomized, double-blind, multicentered, placebo-controlled trial
JS Borer et al.
CIRCULATION (2003)
Contributions of heart rate and contractility to myocardial oxygen balance during exercise
P Colin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Anti-ischemic effects of ivabradine, a selective heart rate-reducing agent, in exercise-induced myocardial ischemia in pigs
JP Vilaine et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2003)
A single intravenous dose of ivabradine, a novel I-f inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction
M Manz et al.
CARDIOLOGY (2003)
Efficacy of monotherapy compared with combined antianginal drugs in the treatment of chronic stable angina pectoris: a meta-analysis
WW Klein et al.
CORONARY ARTERY DISEASE (2002)
Current-dependent block of rabbit sino-atrial node If channels by ivabradine
A Bucchi et al.
JOURNAL OF GENERAL PHYSIOLOGY (2002)
Differential effects of heart rate reduction and β-blockade on left ventricular relaxation during exercise
P Colin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBISII trial
P Lechat et al.
CIRCULATION (2001)
Share Paper
